A conversion of the global terrestrial carbon sink to a source is critically dependent on the microbially mediated decomposition of soil organic matter (SOM). We have developed a detailed, process-based, mechanistic model for simulating SOM decomposition and its associated processes, based on Microbial Kinetics and Thermodynamics, called the MKT model. We formulated the sequential oxidation-reduction potential (ORP) and chemical reactions undergoing at the soil-water zone using dual Michaelis-Menten kinetics. Soil environmental variables, as required in the MKT model, are simulated using one of the most widely used watershed-scale models - the soil water assessment tool (SWAT). The MKT model was calibrated and validated using field-scale data of soil temperature, soil moisture, and NO emissions from three locations in the province of Saskatchewan, Canada. The model evaluation statistics show good performance of the MKT model for daily soil NO simulations. The results show that the proposed MKT model can perform better than the more widely used process-based and SWAT-based models for soil NO simulations. This is because the multiple processes of microbial activities and environmental constraints, which govern the availability of substrates to enzymes were explicitly represented. Most importantly, the MKT model represents a step forward from conceptual carbon pools at varying rates.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.envpol.2019.01.062DOI Listing

Publication Analysis

Top Keywords

mkt model
24
soil
9
model
9
microbial kinetics
8
soil organic
8
organic matter
8
oxidation-reduction potential
8
models soil
8
soil simulations
8
mkt
7

Similar Publications

Background: We developed the FORCE platform to overcome limitations of oligonucleotide delivery to muscle and enable their applicability to neuromuscular disorders. The platform consists of an antigen-binding fragment, highly specific for the human transferrin receptor 1 (TfR1), conjugated to an oligonucleotide via a cleavable valine-citrulline linker. Myotonic dystrophy type 1 (DM1) is a neuromuscular disorder caused by expanded CUG triplets in the DMPK RNA, which sequester splicing proteins in the nucleus, lead to spliceopathy, and drive disease progression.

View Article and Find Full Text PDF

Strategic development of aceclofenac loaded organosomes for topical application: An explorative ex-vivo and in-vivo investigation for arthritis.

Int J Pharm

December 2024

University Institute of Pharmaceutical Sciences, UGC-centre of Advanced Studies, Panjab University, Chandigarh 160014, India. Electronic address:

Article Synopsis
  • The study focuses on creating aceclofenac-encapsulated organosomes (OS) designed to treat arthritis using a unique combination of phospholipids and organic solvents.
  • The OS formulation showed promising characteristics such as a small size, high drug entrapment efficiency, and improved drug permeability compared to a marketed product, leading to better penetration in skin layers.
  • Results from various arthritis models demonstrated that the OS significantly reduced inflammation markers and was more effective in alleviating arthritis symptoms than the marketed product.
View Article and Find Full Text PDF
Article Synopsis
  • * These p16-sn fibroblasts accumulate with age, act as inflammatory cancer-associated fibroblasts (CAFs), and significantly contribute to bladder tumor growth by expressing the CXCL12 gene.
  • * Targeting p16-sn cells or blocking CXCL12 signaling can reduce bladder tumor growth, indicating that these cells create an environment that supports cancer development in older individuals.
View Article and Find Full Text PDF

Understanding the structural dynamics of covalent organic frameworks (COFs) in response to external temperature change is necessary for these materials' application at cryogenic temperatures. Herein, we report reversible structural dynamics observed in covalent organic frameworks as the temperature varies from 298 K to 30 K. A series of frameworks (COF-300, COF-300-amine, and COF-V) was studied using a cryogenic infrared spectroscopy system.

View Article and Find Full Text PDF

Tirzepatide, a glucose-dependent insulinotropic polypeptide/glucagon-like peptide 1 receptor (GIPR/GLP-1R) agonist, has, in clinical trials, demonstrated greater reductions in glucose, body weight, and triglyceride levels compared with selective GLP-1R agonists in people with type 2 diabetes (T2D). However, cellular mechanisms by which GIPR agonism may contribute to these improved efficacy outcomes have not been fully defined. Using human adipocyte and mouse models, we investigated how long-acting GIPR agonists regulate fasted and fed adipocyte functions.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!